Strides Pharma Science Q2 Results: Firm posts net profit of Rs 94.66 crore




Strides Pharma Science reported a consolidated net profit of Rs 93.66 crore for Q2 September 2024, recovering from a net loss of Rs 149.45 crore the previous year.

Comments